Skip to content
MRD Watch

Wednesday, November 18, 2026

Subscribe
Sponsor this briefing. One site and newsletter slot, $250/week.

Briefing

Whole genome sequencing-powered ctDNA sequencing for breast cancer detection.

Plasma from 78 people with early breast cancer was tested with the NeXT Personal MRD platform, a tumor-informed whole-genome assay, across 617 samples.

Annals of OncologyPubMed 39914664DOI 10.1016/j.annonc.2025.01.021